课题基金 / 基金详情

Research on the prediction of hematogenous metastasis and recurrence of hepatocellular carcinoma, pancreatic carcinoma, gastric carcinoma and esophageal carcinoma. (Detection of circulating AFPmRNA,CEAmRNA and Cytokeratin mRNA)

Research on the prediction of hematogenous metastasis and recurrence of hepatocellular carcinoma, pancreatic carcinoma, gastric carcinoma and esophageal carcinoma. (Detection of circulating AFPmRNA,CEAmRNA and Cytokeratin mRNA)
肝细胞癌、胰腺癌、胃癌、食管癌血行转移及复发预测研究。
批准号:
09671301
负责人:
SHIMADA Yutaka
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SHIMADA Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究中,我们以以下mRNA的形式建立了血液中各种胃肠道癌细胞的检测系统(rt -巢式PCR)。肝癌检测到甲胎蛋白(AFP) mRNA,胰腺癌和胃癌检测到癌胚癌抗原(CEA) mRNA,大肠癌检测到细胞角蛋白20mRNA,食管癌检测到鳞状细胞癌抗原(SCC) mRNA。该系统可在1ml血液中检测到1 ~ 5个癌细胞,磁性细胞吸收后免疫组化可清楚地显示外周血中表达CEA或细胞角蛋白的细胞。我们还检测了胰腺癌患者术中门静脉CEA mRNA和食管癌患者术中外周血SCC mRNA。这些事实表明,在手术过程中,癌细胞可以在血液中播散。血液中癌相关mrna的检测与患者预后及复发相关。有患者化疗后未检测到CEA mRNA或SCC mRNA,但给药方案仍存在争议。我们的血液癌细胞检测系统有助于预测患者的预后,并可能为化疗策略提供有益的信息。对血液中癌细胞阳性患者的临床病理和分子生物学分析应在未来进行评估。
英文摘要
In this study, we established detection system (RT-nested PCR) of various gastrointestinal carcinoma cells in blood in the form of following mRNA.Alpha-fetoprotein(AFP) mRNA for hepatocellular carcinoma, carcinoembrionic carcinoma antigen (CEA) mRNA for pancreatic and gastric carcinoma, cytokeratin 20mRNA for colorectal carcinoma, and squamous cell carcinoma antigen (SCC) mRNA for esophageal carcinoma These systems could detect one to five cancer cells in 1ml of blood and magnetic cell absorption followed by immunohistochemistry clearly demonstrated the cells, which express CEA or Cytokeratin in peripheral blood. We also detected CEA mRNA in portal vein during operations in pancreatic carcinoma patients and SCC mRNA in peripheral blood during operations in patients with esophageal carcinoma. These facts show that carcinoma cells can be disseminated in blood during operations.Detection of carcinoma related mRNAs in blood correlated with patients prognosis and recurrence. There were patients whose CEA mRNA or SCC mRNA was not detected after chemotherapy, however the protocols of drug administration remains controversial. Our detection systems of cancer cells in blood are useful for prediction of patients' prognosis and might have beneficial information for strategy of chemotherapy. Clinicopathological as well as molecular biological analysis of the patients with positive cancer cells in blood should be evaluated in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shimada Y: "Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology" Br J Cancer. (in press). (1999)
Shimada Y:“从分子生物学角度探讨食管鳞状细胞癌的预后因素”Br J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimada Y: "Genetic Alterations in Patients with Esophageal Cancer with Short and Long Term Survival Rates after Curative Esophagectony" Ann Surg. 226. 162-168 (1997)
Shimada Y:“食管癌患者的基因改变与根治性食管切除术后短期和长期生存率”Ann Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimada Y.: Esophageal cancers.Human Cell Culture J.R.W.Masters and B.Palsson (eds) Kluwer Academic publishers., 179-212 (1999)
Shimada Y.:食道癌。人类细胞培养 J.R.W.Masters 和 B.Palsson(编)Kluwer 学术出版社,179-212 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Research on the treatment of esophageal cancer with anti-human fibroblast growth factor receptor like-1
    • 批准号:
      26293302
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.4万
    • 财政年份:
      2014
    • 负责人:
      SHIMADA Yutaka
    • 依托单位:
    Detection of gastrointestinal cancer biomarkers by next-generation mass spectrometry and comprehensive gene expression analysis
    Protective effect of Kampo medicine on vascular endothelial functionin patients with metabolic syndrome
    • 批准号:
      22590649
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2010
    • 负责人:
      SHIMADA Yutaka
    • 依托单位:
    Research for the establishment of pluripotent stem cells from normal human culture cells and tissue engineering
    • 批准号:
      22659228
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.04万
    • 财政年份:
      2010
    • 负责人:
      SHIMADA Yutaka
    • 依托单位:
    海外基金